Addenbrooke's Hospital Begins Treating Patients On Second Tomotherapy® Cancer Treatment System

MADISON, WI--(Marketwire - February 2, 2010)versatility of the TomoTherapy system in treating a
- TomoTherapy Incorporated (NASDAQ: TOMO),wide variety of clinical indications," said Frederick A.
maker of advanced radiation therapy solutions forRobertson, M.D., TomoTherapy's president and CEO.
cancer care, announced today that Addenbrooke's"We are pleased that our system's ease of use has
Hospital, which is run by the Cambridge Universityenabled Addenbrooke's to achieve tremendous
Hospitals National Health Service (NHS) Foundationefficiencies while expanding their capabilities to handle
Trust, recently installed and began treating patientscases that range from the common and simple, to
on its second TomoTherapy® radiation therapythe rare and complex."
system.TomoTherapy technology is developed and
"The TomoTherapy platform has proven to be amanufactured by TomoTherapy Inc. and is supplied
highly efficient solution for daily image-guidedin the U.K. by Oncology Systems Limited, based in
radiotherapy with positional correction, and for theShrewsbury, England.
delivery of sophisticated treatment plans usingAbout Oncology Systems Limited
high-quality intensity-modulated radiotherapy," said NeilOncology Systems Limited is a privately owned
Burnet, a consultant oncologist at Addenbrooke's.company based in Shrewsbury, England. OSL is one
"With our second TomoTherapy system now inof the largest suppliers of radiation therapy
operation, we are able to offer this extraordinarytechnology to the U.K. and Ireland. It distributes the
treatment to more patients, expanding our ability toTomoTherapy® Hi*Art® cancer treatment
treat prostate cancer and more complex cases."technology to the U.K.'s NHS and private radiotherapy
In October 2007, Addenbrooke's Hospital became thefacilities, and the Republic of Ireland.
first NHS facility in England to install a TomoTherapyAbout Addenbrooke's Hospital
treatment system. The hospital selected theCambridge University Hospitals, one of the first
TomoTherapy solution because it offered highlyFoundation Trusts, is a 1,000-bed teaching hospital, as
precise, image-guided, intensity-modulated radiationwell as one of the government's new biomedical
therapy (IG-IMRT) in an integrated, easy-to-useresearch centres. It has a world-class research
package. This combination offers clinical flexibility notreputation, whilst also providing acute and specialist
available with other radiation therapy systems, suchservices for its local and regional population.
as the ability to deliver more conformal treatmentsAddenbrooke's radiotherapy service treats over
capable of addressing a wider array of patient needs.4,000 new patients per annum, with 59,000
In addition to Cambridge, TomoTherapy(SM)treatment fractions delivered. In December 2008
treatments are currently available within the NHS inCambridge University Hospitals NHS Foundation Trust
Newcastle and will be available shortly intook the top prize -- Acute Organisation of the Year
Middlesbrough, Nottingham and London, as well as in-- in the U.K.'s annual Health Service Journal Awards.
the private Bupa Cromwell Hospital, London.About TomoTherapy Incorporated
"TomoTherapy delivers on its promises," said DonnaTomoTherapy Incorporated develops, markets and
Routsis, lead research radiographer at Addenbrooke's.sells advanced radiation therapy solutions that can be
"Our experience validates that the TomoTherapyused to treat a wide variety of cancers, from the
system provides superb quality treatment planningmost common to the most complex. The ring
and delivery, as well as fast, easy, accurate andgantry-based TomoTherapy® platform combines
integrated, 3D volumetric image guidance. It hasintegrated CT imaging with conformal radiation
increased our confidence and enables us to approachtherapy to deliver sophisticated radiation treatments
challenging cases that were previously out of reach."with speed and precision while reducing radiation
With its first TomoTherapy system, Addenbrooke'sexposure to surrounding healthy tissue.
Hospital expanded its cancer care capabilities to treatTomoTherapy's suite of solutions include its flagship
more than 50 different types of cancers, includingHi*Art® treatment system, which has been used
cranial and spinal tumors and pediatric cases. Into deliver more than three million CT-guided, helical
addition, Addenbrooke's Hospital began acceptingintensity-modulated radiation therapy (IMRT)
referrals from other facilities not equipped to handletreatment fractions; the TomoHD™ treatment
complex tumors and neurological cases. The hospitalsystem, designed to enable cancer centers to treat a
treats, on average, 31 patients per day with its initialbroader patient population with a single device; and
TomoTherapy unit. Clinicians improved efficiency ofthe TomoMobile™ relocatable radiation therapy
their TomoTherapy treatments with the introductionsolution, designed to improve access and availability
of a High Performance Couch in April 2009, whichof state-of-the-art cancer care. TomoTherapy's
shaves minutes off treatment time by loading andstock is traded on the NASDAQ Global Select Market
unloading patients from the unit with a touch of aunder the symbol TOMO. To learn more about
button. However, continued growing demand forTomoTherapy, please visit 
TomoTherapy treatments resulted in Addenbrooke's©2010 TomoTherapy Incorporated. All rights
decision to purchase its second system. The secondreserved. TomoTherapy, Tomo, TomoDirect, TQA,
system was used to treat its first patient in Januarythe TomoTherapy logo and Hi*Art are among
2010, and the hospital expects that the combinationtrademarks, service marks or registered trademarks
of the two units will enable them to treat more thanof TomoTherapy Incorporated in the United States
60 patients per day.and other countries.
"Addenbrooke's experience truly showcases the